Skip to main content

Pemazyre Prices, Coupons and Patient Assistance Programs

Pemazyre (pemigatinib) is a member of the multikinase inhibitors drug class and is commonly used for Cholangiocarcinoma, and Myeloid/Lymphoid Neoplasms.

The cost for Pemazyre oral tablet 4.5 mg is around $18,448 for a supply of 14 tablets, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Pemazyre is available as a brand name drug only, a generic version is not yet available. View generic Pemazyre availability for more details.

Pemazyre prices

Oral Tablet

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Pemazyre Coupons, Copay Cards and Rebates

Pemazyre offers may be in the form of a printable coupon, rebate, savings or copay card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Pemazyre IncyteCARES Savings Program: Eligible commercially insured patients may pay as little as $0 copay with a savings of up to $9000 per treatment; maximum savings of $25,000 per year; for additional information contact the program at 855-452-5234.

Applies to:
Pemazyre
Number of uses:
per prescription per year

Form more information phone: 855-452-5234 or Visit website

Pemazyre IncyteCARES Temporary Access Program: Eligible commercially insured patient may receive a FREE 30-day supply if experiencing a delay in coverage; for additional information contact the program at 855-452-5234.

Applies to:
Pemazyre
Number of uses:
Temporary Assistance

Form more information phone: 855-452-5234 or Visit website

Patient Assistance & Copay Programs for Pemazyre

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines and copay programs to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Pemazyre (pemigatinib) Tablet

More information please phone: 866-316-7263 Visit Website

Provider: IncyteCARES Patient Assistance Program: Pemazyre

Elligibility requirements:
  1. Contact program for details.
  2. Varies
  3. FDA-approved diagnosis
  4. Must be residing in the US or Puerto Rico
  5. Patient or doctor's office can call the program to apply. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Conditional approval for 90 days. Education and support services are available. This program also provides copay/coinsurance assistance for commercially/privately insured patients Prescribers can enroll the patient online via the IncyteCARES.com website.
Applicable drugs:
  • Pemazyre (pemigatinib) Tablet

More information please phone: 855-452-5234 Visit Website